Cargando…
Immune Globulin Subcutaneous (Human) 20%: In Primary Immunodeficiency Disorders
Immune globulin subcutaneous 20% is a new high-concentration (200 g/L) solution of highly purified human IgG (≥98%) indicated in the EU and the US for antibody replacement therapy in patients with primary immunodeficiency with antibody deficiency, and in the EU for replacement therapy in humoral imm...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582812/ https://www.ncbi.nlm.nih.gov/pubmed/22621695 http://dx.doi.org/10.2165/11209490-000000000-00000 |